Viewing Study NCT01429116


Ignite Creation Date: 2025-12-26 @ 11:46 AM
Ignite Modification Date: 2025-12-26 @ 11:46 AM
Study NCT ID: NCT01429116
Status: COMPLETED
Last Update Posted: 2015-04-21
First Post: 2011-08-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Sponsor: Vanda Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module